Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...
Nina S. Kjellson, a director at Tyra Biosciences , Inc. (NASDAQ:TYRA), recently sold shares of the company's common stock totaling $74,323. The timing of this insider sale comes as the stock trades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback